Gene delivery by embryonic stem cells for malignant glioma therapy - Hype or hope?

被引:24
作者
Germano, Isabelle M. [1 ]
Uzzaman, Mahmud [1 ]
Keller, Gordon [1 ]
机构
[1] Mt Sinai Sch Med, Director Stereotact Program, New York, NY 10029 USA
关键词
glioblastoma; stem cells; gene therapy; apoptosis;
D O I
10.4161/cbt.7.9.6711
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Patients with glioblastomas have a poor prognosis and new treatments paradigms are needed. The futility of current treatments lies in part on the difficulty of delivering therapeutic agents to the tumor. In this article, we review and discuss current knowledge of adjuvant treatment for glioblastomas including gene therapy and viral vectors. Additionally, this review provides an update on recent progress, which has focused on improving delivery methods including the development of new approaches such as stem cells. Particular emphasis is given to laboratory data showing the use of embryonic stem cells used as vectors to deliver pro-apoptotic genes to glioblastoma cells.
引用
收藏
页码:1341 / 1347
页数:7
相关论文
共 52 条
[1]
Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas [J].
Aboody, KS ;
Brown, A ;
Rainov, NG ;
Bower, KA ;
Liu, SX ;
Yang, W ;
Small, JE ;
Herrlinger, U ;
Ourednik, V ;
Black, PM ;
Breakefield, XO ;
Snyder, EY .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (23) :12846-12851
[2]
Neural precursor cells as carriers for a gene therapeutical approach in tumor therapy [J].
Arnhold, S ;
Hilgers, M ;
Lenartz, D ;
Semkova, I ;
Kochanek, S ;
Voges, J ;
Andressen, C ;
Addicks, K .
CELL TRANSPLANTATION, 2003, 12 (08) :827-837
[3]
Safety and antitumor activity of recombinant soluble Apo2 ligand [J].
Ashkenazi, A ;
Pai, RC ;
Fong, S ;
Leung, S ;
Lawrence, DA ;
Masters, SA ;
Blackie, C ;
Chang, L ;
McMurtrey, AE ;
Hebert, A ;
DeForge, L ;
Koumenis, IL ;
Lewis, D ;
Harris, L ;
Bussiere, J ;
Koeppen, H ;
Shahrokh, Z ;
Schwall, RH .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) :155-162
[4]
BENVENISTE R, 2003, NEUROSURG FOCUS, V14, P1, DOI DOI 10.3171/FOC.2003.14.2.6
[5]
Embryonic stem cell-derived astrocytes expressing drug-inducible transgenes: differentiation and transplantion into the mouse brain [J].
Benveniste, RJ ;
Keller, G ;
Germano, I .
JOURNAL OF NEUROSURGERY, 2005, 103 (01) :115-123
[6]
Embryonic stem cell-derived glial precursors:: A source of myelinating transplants [J].
Brüstle, O ;
Jones, KN ;
Learish, RD ;
Karram, K ;
Choudhary, K ;
Wiestler, OD ;
Duncan, ID ;
McKay, RDG .
SCIENCE, 1999, 285 (5428) :754-756
[7]
CBTRUS, 2005, PRIM BRAIN TUM US ST
[8]
Astrocytes and brain injury [J].
Chen, YM ;
Swanson, RA .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2003, 23 (02) :137-149
[9]
Anatomical and functional recovery by embryonic stem cell-derived neural tissue of a mouse model of brain damage [J].
Chiba, S ;
Ikeda, R ;
Kurokawa, MS ;
Yoshikawa, H ;
Takeno, M ;
Nagafuchi, H ;
Tadokoro, M ;
Sekino, H ;
Hashimoto, T ;
Suzuki, N .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2004, 219 (1-2) :107-117
[10]
Gene therapy: A primer for neurosurgeons [J].
Chiocca, EA .
NEUROSURGERY, 2003, 53 (02) :364-373